Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study

Table 2 Baseline characteristics of participants

Measurement	Mean ± SD
Anthropomorphic
Age (yr)	53.8 ± 9.11
Weight	100.6 ± 21.75 kg
BMI	36.9 ± 8.29 kg/m2
Waist circumference (reference < 88 female, < 102 male)	109.6 ± 11.1 cm
Daily hours fasted	11.6 ± 1.9 h/d
Systolic BP (mmHg) T2DM goal < 130	130.00 ± 17.80
Diastolic BP (mmHg) T2DM goal < 80	80.50 ± 13.20
Biochemical
C-reactive protein (mg/L) (reference < 1.0 mg/L)	4.31 ± 3.80
HOMA-IR calculated (normal < 2.5)	6.91 ± 3.00
Fasting glucose (normal < 7.0 mmol/L)	7.45 ± 1.52 mmol/L
Medications present during study period
Metformin	10 (10)
Sulfonylureas	1 (10)
Other diabetic medications	1 (10)
Other non-diabetic medications	8 (10)

T2DM: Type 2 diabetes mellitus; HOMA-IR: Homeostasis Model Assessment; BMI: Body mass index; BP: Blood pressure.